Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
1.
Eur Rev Med Pharmacol Sci ; 23(2 Suppl): 51-58, 2019 Apr.
Article in English | MEDLINE | ID: mdl-30977871

ABSTRACT

OBJECTIVE: The increasing number of total knee arthroplasties performed yearly worldwide has resulted in a concomitant rise in bacterial infections. Two-stage reimplantation has been reported as the most successful method of treating periprosthetic knee infections. The purpose of this study was to describe all the phases of the two-stage reimplantation and to review the literature regarding the topic. MATERIALS AND METHODS: Most significant and recent papers about the management of periprosthetic knee infection through a two-stage reimplantation protocol were carefully analysed and reviewed. Our personal experience, previously published, with two-stage-reimplantation protocol was also briefly reported. RESULTS: Two-stage reimplantation has been reported as the most successful method of treating periprosthetic knee infections. The strategy of using an antibiotic-loaded cement spacer and intravenous antibiotics with delayed exchange arthroplasty is actually considered the state-of-the-art, with a reported success rate of 88-96%. The two-stage protocol has been reported as a viable option also for patients with a periprosthetic knee infection by multidrug-resistant organisms. On the other hand, open debridement with polyethylene exchange and single-stage reimplantation have been reported effective only in selective case series involving acute infections by low-virulence organisms. CONCLUSIONS: The strategy that involves the use of cement spacer, intravenous antibiotic therapy, and successive revision total knee implantation is nowadays considered the gold standard for the management of the periprosthetic knee infection. This treatment is actually considered the first choice not only for chronic but also for acute infections, especially in the presence of resistant bacteria.


Subject(s)
Arthroplasty, Replacement, Knee , Prosthesis-Related Infections/surgery , Anti-Bacterial Agents/therapeutic use , Humans , Prosthesis-Related Infections/diagnosis , Prosthesis-Related Infections/drug therapy , Prosthesis-Related Infections/microbiology
2.
Knee Surg Sports Traumatol Arthrosc ; 24(10): 3168-3174, 2016 Oct.
Article in English | MEDLINE | ID: mdl-27600633

ABSTRACT

PURPOSE: Antibiotic-loaded bone cement has been widely used for the treatment of infected knee replacement, but its routine use in primary TKA remains controversial. The aim of this systematic review was to analyze the literature about the antimicrobial efficacy and safety of antibiotic-loaded bone cement for its prophylactic use in primary TKA. METHODS: A detailed and systematic search of the Pubmed, Medline, Cochrane Reviews and Google Scholar databases had been performed using the keyword "total knee arthroplasty" "total knee replacement" "total knee prosthesis" and "antibiotic-loaded bone cement" with no limit regarding the year of publication. We used modified Coleman scoring methodology (mCMS) to identify scientifically sound articles in a reproducible format. The review was limited to the English-language articles. RESULTS: Six articles met inclusion criteria. In total, 6318 arthroplasties were included in our study. 3217 of these arthroplasties received antibiotic-loaded bone cement and 3101 arthroplasties served as the control. There was no statistical difference between the two groups in terms of the incidence of deep or superficial surgical site infection. The average mCMS score was 67.6, indicating good methodological quality in the included studies. CONCLUSIONS: Present review did not reveal any significant difference in terms of rate of deep or superficial surgical site infection in patients receiving antibiotic-loaded bone cement compared with the control (plain bone cement) during primary TKA. The clinical relevance of this study was that the use of antibiotic-loaded bone cement did not significantly reduce the risk of infection in primary TKA. LEVEL OF EVIDENCE: III.


Subject(s)
Anti-Bacterial Agents/administration & dosage , Arthroplasty, Replacement, Knee , Bone Cements , Prosthesis-Related Infections/prevention & control , Humans , Knee Prosthesis
3.
Cell Death Dis ; 4: e732, 2013 Jul 18.
Article in English | MEDLINE | ID: mdl-23868065

ABSTRACT

Cancer cells, which use more glucose than normal cells and accumulate extracellular lactate even under normoxic conditions (Warburg effect), have been reported to undergo cell death under glucose deprivation, whereas normal cells remain viable. As it may be relevant to exploit the molecular mechanisms underlying this biological response to achieve new cancer therapies, in this paper we sought to identify them by using transcriptome and proteome analysis applied to an established glucose-addicted cellular model of transformation, namely, murine NIH-3T3 fibroblasts harboring an oncogenic K-RAS gene, compared with parental cells. Noteworthy is that the analyses performed in high- and low-glucose cultures indicate that reduction of glucose availability induces, especially in transformed cells, a significant increase in the expression of several unfolded protein response (UPR) hallmark genes. We show that this response is strictly associated with transformed cell death, given that its attenuation, by reducing protein translation or by increasing cell protein folding capacity, preserves the survival of transformed cells. Such an effect is also observed by inhibiting c-Jun NH2-terminal kinase, a pro-apoptotic signaling mediator set downstream of UPR. Strikingly, addition of N-acetyl-D-glucosamine, a specific substrate for the hexosamine biosynthesis pathway (HBP), to glucose-depleted cells completely prevents transformed cell death, stressing the important role of glucose in HBP fuelling to ensure UPR attenuation and increased cell survival. Interestingly, these results have been fully recognized in a human model of breast cancer, MDA-MB-231 cells. In conclusion, we show that glucose deprivation, leading to harmful accumulation of unfolded proteins in consequence of a reduction of protein glycosylation, induces a UPR-dependent cell death mechanism. These findings may open the way for new therapeutic strategies to specifically kill glycolytic cancer cells.


Subject(s)
Apoptosis , Glucose/deficiency , Hexosamines/biosynthesis , Proto-Oncogene Proteins/genetics , Unfolded Protein Response , ras Proteins/genetics , Acetylglucosamine/physiology , Animals , Biosynthetic Pathways , Cell Line, Transformed , Cell Line, Tumor , Cell Survival , Endoplasmic Reticulum Stress , Gene Regulatory Networks , Humans , JNK Mitogen-Activated Protein Kinases/metabolism , Mice , NIH 3T3 Cells , Protein Biosynthesis , Proto-Oncogene Proteins/metabolism , Proto-Oncogene Proteins p21(ras) , RNA, Messenger/genetics , RNA, Messenger/metabolism , Transcriptome , ras Proteins/metabolism
4.
Int J Immunopathol Pharmacol ; 24(3): 711-9, 2011.
Article in English | MEDLINE | ID: mdl-21978703

ABSTRACT

Metallosis represents a rare and severe complication of knee replacement surgery. It is caused by the infiltration and accumulation of metallic debris into the peri-prosthetic structures, deriving from friction between metallic prosthetic components. In knee arthroplasty, this event generally occurs as a result of polyethylene wear of the tibial or metal-back patellar component. The real incidence of metallosis is still unknown, although it seems to be more frequent in hip than in knee arthroplasty. The metallic debris induces a massive release of cytokines from inflammatory cells, making a revision necessary whenever osteolysis and loosening of the prosthesis occur. We report four patients who underwent revision of their knee arthroplasty because of severe metallosis. In one of these patients, polyethylene wear had determined friction between the metal-back patellar component and the anterior portion of the femoral component. In the remaining three cases, metallosis was caused by friction between the femoral and tibial prosthetic metal surfaces, resulting from full-thickness wear of the tibial polyethylene. T lymphocytes were activated by metal particles present in periprosthetic membranes. In all patients, one-stage revision was necessary, with rapid pain disappearance and a complete functional recovery of the knee joint.


Subject(s)
Arthroplasty, Replacement, Knee/adverse effects , Biocompatible Materials/adverse effects , Knee Prosthesis/adverse effects , Metals/adverse effects , Prostheses and Implants/adverse effects , Aged , Cytokines/metabolism , Female , Friction , Humans , Male , Necrosis , Polyethylenes , Prosthesis Failure , Replantation , Surface Properties , Synovial Membrane/pathology , Synovitis/chemically induced , Synovitis/pathology , T-Lymphocytes/immunology , T-Lymphocytes/physiology
5.
Int J Immunopathol Pharmacol ; 24(1 Suppl 2): 149-52, 2011.
Article in English | MEDLINE | ID: mdl-21669155

ABSTRACT

Cartilage defects represent a common problem in orthopaedic practice. The knee is frequently involved and the medial femoral condyle is the most common localization. Predisposing factors are: traumas, inflammatory conditions and biomechanics alterations. Several surgical options are available once correct diagnosis is given and accurate patient evaluation has been performed. The aim of our study was to prospectively evaluate functional results of modified autologous matrix induced chondrogenesis (AMIC) technique in a population of patients affected by focal cartilage defects A population of 17 patients was enrolled in this study. 10 patients were male, mean age at the time of surgery was 39 years, right side was involved in 11 cases. All patients were evaluated with accurate physical exam and complete imaging study. At an average FU of 36 months, mean IKDC score and Lysholm score improved from 32 to 82 and from 38 to 74. 13 patients out of 17 (76.5%) were satisfied or extremely satisfied with their functional result. MRI control showed reduction of the defect area and subchondral oedema in 10 cases (58.8%). AMIC technique is a relatively new option in the treatment of full thickness cartilage lesions. It enhances the advantages of microfractures since the Chondrogide membrane protects and stabilizes the blood plug acting as a matrix for new cartilage formation. First reports on AMIC technique, show comparable results to autologous chondrocyte implantation (ACI) with the advantage of a single stage technique and no donor site morbidity. AMIC technique represents a new option in the treatment of full thickness cartilage defect. It is safe and reliable. Our data are in accordance with previously reported series in literature and confirm the good objective and subjective results of this procedure.


Subject(s)
Cartilage Diseases/therapy , Cartilage, Articular/pathology , Chondrogenesis/physiology , Knee Joint/pathology , Adult , Aged , Cartilage Diseases/surgery , Cartilage, Articular/surgery , Female , Femur/pathology , Fractures, Cartilage/pathology , Fractures, Cartilage/surgery , Humans , Magnetic Resonance Imaging , Male , Middle Aged , Orthopedic Procedures , Patella/pathology , Transplantation, Autologous , Treatment Outcome , Young Adult
SELECTION OF CITATIONS
SEARCH DETAIL